Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 13, 2023

BUY
$204.38 - $296.82 $2.93 Million - $4.25 Million
14,321 Added 487.61%
17,258 $3.55 Million
Q3 2022

Nov 14, 2022

BUY
$195.21 - $310.53 $573,331 - $912,026
2,937 New
2,937 $817,000
Q2 2022

Aug 11, 2022

SELL
$115.91 - $214.48 $433,155 - $801,511
-3,737 Closed
0 $0
Q1 2022

May 13, 2022

BUY
$127.96 - $207.36 $478,186 - $774,904
3,737 New
3,737 $775,000
Q2 2021

Aug 12, 2021

SELL
$131.45 - $201.49 $443,775 - $680,230
-3,376 Closed
0 $0
Q1 2021

May 13, 2021

SELL
$92.73 - $142.05 $172,570 - $264,355
-1,861 Reduced 35.54%
3,376 $440,000
Q4 2020

Feb 11, 2021

SELL
$67.44 - $103.72 $71,688 - $110,254
-1,063 Reduced 16.87%
5,237 $543,000
Q3 2020

Nov 06, 2020

BUY
$42.79 - $75.8 $269,577 - $477,540
6,300 New
6,300 $478,000

Others Institutions Holding SWAV

About Shockwave Medical, Inc.


  • Ticker SWAV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 35,927,100
  • Description
  • ShockWave Medical, Inc., a medical device company, engages in developing and commercializing intravascular lithotripsy technology for the treatment of calcified plaque in patients with peripheral vascular, coronary vascular, and heart valve diseases worldwide. The company offers M5 catheters for treating above-the-knee peripheral artery disease ...
More about SWAV
Track This Portfolio

Track Trexquant Investment LP Portfolio

Follow Trexquant Investment LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Trexquant Investment LP, based on Form 13F filings with the SEC.

News

Stay updated on Trexquant Investment LP with notifications on news.